Certified Hyperbaric Technologist Practice Test

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the Certified Hyperbaric Technologist Test using flashcards and multiple-choice questions with detailed explanations. Enhance your readiness and ace your certification exam!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


What should be considered when a patient with a wound needs HBOT and has been treated with cis-platinum?

  1. Patient's ability to tolerate HBO therapy

  2. Wound breaking strength

  3. Age of the wound

  4. Type of medical insurance

The correct answer is: Wound breaking strength

When considering a patient who requires hyperbaric oxygen therapy (HBOT) after being treated with cis-platinum, wound breaking strength is a critical factor because chemotherapy agents like cis-platinum can have a significant impact on tissue healing. Cis-platinum is known to have cytotoxic effects, which can compromise the integrity and strength of the wound. Therefore, understanding the wound breaking strength is vital to assess how well the wound can tolerate the hyperbaric oxygen treatments and to predict the healing outcomes. This consideration allows healthcare providers to strategize around the patient's wound management effectively and decide the appropriateness of HBOT based on the condition of the wound itself. The health professional can determine whether the wound is conducive to treatment and what precautions may need to be taken to optimize healing. Looking at other factors, while the patient's ability to tolerate HBO therapy is important, it is more a general consideration rather than specific to the effects of cis-platinum. The age of the wound can provide information about chronicity and time for healing, but it does not directly relate to how cis-platinum has affected tissue repair. Additionally, type of medical insurance may influence access to treatment but does not impact the biological aspects of wound healing or the decision to proceed with HBOT based on